Why do old

Overview

Aging is a complex biological process involving progressive physiological decline that increases vulnerability to disease and death. Historically, human life expectancy was much shorter—averaging around 30-40 years in pre-industrial societies—but has dramatically increased due to medical advances, improved sanitation, and better nutrition. The 20th century saw particularly rapid gains, with global life expectancy rising from 46.5 years in 1950 to 72.8 years in 2019 according to WHO data. This demographic shift has created aging populations worldwide, with Japan having the highest proportion of elderly at 28% of its population over 65. The study of aging (gerontology) dates back to ancient civilizations, but modern understanding began with Leonard Hayflick's 1961 discovery that normal human cells have a limited division capacity (the Hayflick limit), typically 40-60 divisions before senescence.

How It Works

Aging occurs through multiple interconnected biological mechanisms at cellular and molecular levels. Key processes include telomere shortening—protective caps on chromosome ends that erode with each cell division, eventually triggering cellular senescence when they become too short. Mitochondrial dysfunction reduces energy production and increases oxidative stress through reactive oxygen species. Epigenetic changes alter gene expression patterns without changing DNA sequence, while protein homeostasis declines leading to misfolded protein accumulation. Cellular senescence involves cells entering a permanent growth arrest, secreting inflammatory factors that can damage nearby tissues. The immune system also undergoes immunosenescence, reducing effectiveness against pathogens while increasing chronic inflammation (inflammaging). These processes interact through nine established hallmarks of aging including genomic instability, telomere attrition, epigenetic alterations, loss of proteostasis, deregulated nutrient sensing, mitochondrial dysfunction, cellular senescence, stem cell exhaustion, and altered intercellular communication.

Why It Matters

Understanding aging has profound implications for healthcare, economics, and society. With populations aging globally—the UN projects those over 65 will outnumber children under 5 by 2024—healthcare systems face increasing pressure from age-related diseases. Chronic conditions associated with aging account for approximately 71% of global deaths according to WHO. Research into aging mechanisms drives development of interventions like senolytics (drugs that clear senescent cells) and lifestyle approaches that may extend healthspan. Economically, aging populations affect workforce dynamics, pension systems, and intergenerational equity. Socially, it necessitates rethinking housing, transportation, and community design for older adults. Successful aging research could potentially delay multiple age-related diseases simultaneously rather than treating them individually, offering significant quality of life improvements and healthcare cost reductions.